NAFDAC discontinues registration of Artemether/Lumefantrine oral suspension

The National Agency for Food and Drug Administration and Control (NAFDAC) has discontinued the registration of Multi-Dose Anti-Malarial (Artemether/Lumefantrine) dry powder for oral suspension. The announcement was made in a